View 
FILTERS (0)
* Not connected to ResearchPool

MORE FILTERS

  
reports
Andreas Riemann ... (+3)
  • Andreas Riemann
  • Jean Danjou
  • Usama Tariq

ODDO BHF Small & MIDCAP MORNING NEWS - 03/28/2024

With the exception of the US, construction markets should continue to shrink in 2024 (-2% in Europe) before rebounding on the back of lower interest rates. Against this backdrop, groups will be differentiated mainly on the basis of their resilience (geographical and price/cost mix), capital allocation (and special situations) and valuation. In this context, we are upgrading our recommendations on KONE (modernisation as an alternative source of growth to China) and Holcim (a substantia...

Andreas Riemann ... (+3)
  • Andreas Riemann
  • Jean Danjou
  • Usama Tariq

ODDO BHF Small & MIDCAP MORNING NEWS - 28/03/2024

Hormis les Etats-Unis, les marchés de la construction devraient continuer à reculer en 2024 (-2% en Europe) avant de rebondir à la faveur d’une baisse des taux. Dans ce contexte, la différenciation entre les groupes se fera essentiellement sur leur capacité de résistance (mix géographique et prix/ coûts), l’allocation du capital (et situations spéciales) et leur valorisation. Face à cet environnement, nous relevons nos recommandations sur KONE (la modernisation comme relais de la Chin...

Oliver Metzger
  • Oliver Metzger

STRATEC SE : FY review – Sequential improvement, but guidance looks we...

>Top line with positive momentum, but below expectations - Stratec’s Q4 2023 revenues of € 74.2m (+10.8% y-o-y) profited from +12.9% growth in constant currencies), which were 4%/3% below our and the consensus’ expectations. The consolidation of Natech Plastics contributed around 500bp to revenues growth. We like that the company has returned to organic growth in the last quarter, albeit less pronounced than anticipated.Bottom line with sequential growth ...

 PRESS RELEASE

EQS-News: STRATEC BERICHTET ZAHLEN FÜR DAS GESCHÄFTSJAHR 2023

EQS-News: STRATEC SE / Schlagwort(e): Jahresergebnis STRATEC BERICHTET ZAHLEN FÜR DAS GESCHÄFTSJAHR 2023 28.03.2024 / 06:55 CET/CEST Für den Inhalt der Mitteilung ist der Emittent / Herausgeber verantwortlich. STRATEC BERICHTET ZAHLEN FÜR DAS GESCHÄFTSJAHR 2023 Konzernumsatz 2023 währungsbereinigt -3,8% auf 261,9 Mio. € (2022: 274,6 Mio. €);  Währungsbereinigt +12,9% in Q4/2023 Adjustierte EBIT-Marge mit 10,3% (2022: 16,4%) im Bereich des Prognosekorridors Neue Produkteinführung und neu geschlossene Entwicklungskooperationen mit Partnern Ausblick für 2024: Währungsbe...

 PRESS RELEASE

EQS-News: STRATEC REPORTS RESULTS FOR 2023 FINANCIAL YEAR

EQS-News: STRATEC SE / Key word(s): Annual Results STRATEC REPORTS RESULTS FOR 2023 FINANCIAL YEAR 28.03.2024 / 06:55 CET/CEST The issuer is solely responsible for the content of this announcement. STRATEC REPORTS RESULTS FOR 2023 FINANCIAL YEAR Consolidated sales in 2023 -3.8% at constant currency to € 261.9 million (2022: € 274.6 million); Constant-currency growth of 12.9% in Q4/2023 Adjusted EBIT margin of 10.3% (2022: 16.4%) within guidance corridor New product launch and newly concluded development cooperations with partners 2024 guidance: Sales on a constant-cu...

 PRESS RELEASE

EQS-News: STRATEC NIMMT AN DER 42. JÄHRLICHEN J.P. MORGAN HEALTHCARE C...

EQS-News: STRATEC SE / Schlagwort(e): Konferenz STRATEC NIMMT AN DER 42. JÄHRLICHEN J.P. MORGAN HEALTHCARE CONFERENCE TEIL 21.12.2023 / 16:59 CET/CEST Für den Inhalt der Mitteilung ist der Emittent / Herausgeber verantwortlich. STRATEC NIMMT AN DER 42. JÄHRLICHEN J.P. MORGAN HEALTHCARE CONFERENCE TEIL Birkenfeld, 21. Dezember 2023 Die STRATEC SE, Birkenfeld, Deutschland, (Frankfurt: SBS; Prime Standard, SDAX) wird an der 42. jährlichen J.P. Morgan Healthcare Conference am Donnerstag, den 11. Januar 2024, im Westin St. Francis in San Francisco, CA, USA, teilnehmen. Marc...

 PRESS RELEASE

EQS-News: STRATEC TO PARTICIPATE IN THE 42ND ANNUAL J.P. MORGAN HEALTH...

EQS-News: STRATEC SE / Key word(s): Conference STRATEC TO PARTICIPATE IN THE 42ND ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE 21.12.2023 / 16:59 CET/CEST The issuer is solely responsible for the content of this announcement. STRATEC TO PARTICIPATE IN THE 42ND ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE Birkenfeld, December 21, 2023 STRATEC SE, Birkenfeld, Germany, (Frankfurt: SBS; Prime Standard, SDAX) will participate in the 42nd Annual J.P. Morgan Healthcare Conference on Thursday, January 11, 2024, at the Westin St. Francis in San Francisco, CA, USA. Marcus Wolfinger, Chi...

Oliver Metzger
  • Oliver Metzger

STRATEC SE : High dependency on the final quarter

>Top-line guidance reduction factored in - Stratec expects its consolidated sales on a constant-currency basis to fall slightly short of the previous year’s figure in its adjusted guidance for FY 2023 (previously stable or slight sales growth) at constant currencies. The acquisition of Natech Plastic, completed as of 1 July 2023, is expected to contribute around 3.0 percentage points to sales volumes. We now forecast an organic decline of -6.5% (previously -1.0%) for ...

Oliver Metzger
  • Oliver Metzger

STRATEC SE : Q3 review - Slight top line guidance adjustment already w...

>Q3 review – Miss on top line, better on EBIT - Stratec’s Q3 revenues of € 62.7m (-11.0% y-o-y) were impacted by an organic decline of -9.1%. The sales performance was affected by the ongoing subdued developments in the molecular diagnostics instrumentation solutions market. Our forecast stood at € 67m. Adj. EBIT reached € 9.3m (-46% y-o-y, margin 14.8%), which was ahead of our forecast of € 8m. Margin development was negatively impacted by negative effects ...

 PRESS RELEASE

EQS-News: STRATEC REPORTS RESULTS FOR FIRST NINE MONTHS OF 2023

EQS-News: STRATEC SE / Key word(s): Quarter Results STRATEC REPORTS RESULTS FOR FIRST NINE MONTHS OF 2023 27.10.2023 / 06:55 CET/CEST The issuer is solely responsible for the content of this announcement. STRATEC REPORTS RESULTS FOR FIRST NINE MONTHS OF 2023 Significant intra-year improvement in profitability in third quarter of 2023 (adjusted EBIT margin of 14.8% in Q3/2023); adjusted EBIT margin of 8.6% in 9M/2023 (9M/2022: 18.3%) Sales performance still adversely affected by excess molecular diagnostics capacities built up during pandemic; constant-currency sales -9...

 PRESS RELEASE

EQS-News: STRATEC BERICHTET ERGEBNISSE FÜR DIE ERSTEN NEUN MONATE 2023

EQS-News: STRATEC SE / Schlagwort(e): Quartalsergebnis STRATEC BERICHTET ERGEBNISSE FÜR DIE ERSTEN NEUN MONATE 2023 27.10.2023 / 06:55 CET/CEST Für den Inhalt der Mitteilung ist der Emittent / Herausgeber verantwortlich. STRATEC BERICHTET ERGEBNISSE FÜR DIE ERSTEN NEUN MONATE 2023 Unterjährig deutliche Steigerung der Profitabilität im dritten Quartal 2023 (adjustierte EBIT-Marge Q3/2023 bei 14,8%); adjustierte EBIT-Marge 9M/2023 bei 8,6% (9M/2022: 18,3%) Umsatzentwicklung weiterhin durch die in der Pandemie entstandenen Überkapazitäten im Bereich der molekularen Diagno...

 PRESS RELEASE

EQS-News: STRATEC POSTS FINAL RESULTS FOR FIRST HALF OF 2023

EQS-News: STRATEC SE / Key word(s): Half Year Results/Half Year Report STRATEC POSTS FINAL RESULTS FOR FIRST HALF OF 2023 09.08.2023 / 06:55 CET/CEST The issuer is solely responsible for the content of this announcement. STRATEC POSTS FINAL RESULTS FOR FIRST HALF OF 2023 Consolidated sales in H1/2023 -8.9% to € 125.0 million (H1/2022: € 137.2 million); +4.4% in Q2/2023 Adjusted EBIT margin at 5.6% (H1/2022: 15.4%) Further market launches for customers and strong development pipeline underpin positive medium to long-term growth prospects North America business further...

 PRESS RELEASE

EQS-News: STRATEC MIT FINALEN ZAHLEN ZUM ERSTEN HALBJAHR 2023

EQS-News: STRATEC SE / Schlagwort(e): Halbjahresergebnis/Halbjahresbericht STRATEC MIT FINALEN ZAHLEN ZUM ERSTEN HALBJAHR 2023 09.08.2023 / 06:55 CET/CEST Für den Inhalt der Mitteilung ist der Emittent / Herausgeber verantwortlich. STRATEC MIT FINALEN ZAHLEN ZUM ERSTEN HALBJAHR 2023 Konzernumsatz H1/2023 -8,9% auf 125,0 Mio. € (H1/2022: 137,2 Mio. €); +4,4% in Q2/2023 Adjustierte EBIT-Marge bei 5,6% (H1/2022: 15,4%) Weitere Markteinführungen für Kunden und starke Entwicklungspipeline untermauern die positiven mittel- bis langfristigen Wachstumsperspektiven Weitere St...

Luis de Toledo Heras
  • Luis de Toledo Heras

ODDO BHF Small & MIDCAP MORNING NEWS - 07/19/2023

We see United Internet making a gradual exit from IONOS by end-2025. For a player like OVHcloud, which lacks critical mass, we see this as a rare strategic opportunity that shareholders should consider, especially as the two groups happen to have similar valuations. On our estimates, potential synergies represent € 1.2bn in net present value (i.e. >€ 4 per IONOS share and >€ 3 per OVHcloud share). In this report, we will look at the ins and outs of such a merger. In the meantime, we c...

Luis de Toledo Heras
  • Luis de Toledo Heras

ODDO BHF Small & MIDCAP MORNING NEWS - 19/07/2023

Nous voyons United Internet se désengager progressivement du capital d’IONOS d’ici fin 2025. Pour un acteur en manque de taille critique comme OVHcloud, nous pensons que c’est une rare opportunité stratégique que les actionnaires devraient considérer, d’autant que les deux groupes ont des valorisations proches. Nous analysons les tenants et aboutissants d’un tel rapprochement dans cette étude et calculons des synergies possibles pour une valeur actuelle nette de 1,2 Md€ (soit >4 € par...

Oliver Metzger
  • Oliver Metzger

STRATEC SE : No turn for the better – reduced guidance

>Weak second quarter on top line - Stratec reported preliminary H1 2023 revenues of € 125m (-8.9% y-o-y, -9.1% in constant currencies), which translate to Q2 revenues of € 64.5m compared to our forecast of € 69.5m. The corresponding miss to our second quarter revenues forecast and consensus was at around 10%. The company mentioned revised order forecasts of customers, destocking of customers post the pandemic, delivery backlogs with a new system for a veterinary diagn...

Loading...
New interest

Save your current filters as a new Interest

Please enter a name for this interest

Email alerts

Would you like to receive real-time email alerts when a new report is published under this interest?

Save This Search

These search results will show up under 'Saved searches' in the left panel

Please enter a name for this saved search

ResearchPool Subscriptions

Get the most out of your insights

Get in touch